Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | PTPN11 | Q06124 | 5/20 | 0.45 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18284326 | 0.84 | RAB9A (0.52) | RAB9ASMN1; SMN2KDM4EMEN1KMT2A | |
| SCHEMBL25231242 | 0.84 | CYP2C19 (0.52) | RAB9ASMN1; SMN2KDM4EMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL25284530 | 0.82 | BLM (0.53) | RAB9ASMN1; SMN2KDM4EMEN1KMT2A | |
| SCHEMBL6789960 | 0.80 | ALDH1A1 (0.47) | RAB9ASMN1; SMN2KDM4EMEN1KMT2A | |
| SCHEMBL8939614 | 0.79 | RAB9A (0.64) | RAB9ASMN1; SMN2KDM4EMEN1KMT2A | |
| SCHEMBL11117957 | 0.77 | RAB9A (0.57) | RAB9ASMN1; SMN2KDM4EMEN1KMT2A | |
| SCHEMBL10778839 | 0.74 | SMN1; SMN2 (0.52) | RAB9ASMN1; SMN2KMT2ANPC1MAPT | |
| SCHEMBL16346777 | 0.74 | RAB9A (0.48) | RAB9ASMN1; SMN2KDM4EMEN1KMT2A | |
| SCHEMBL27872143 | 0.74 | EPHX2 (0.42) | RAB9ASMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL3122523 | 0.74 | CYP2C19 (0.48) | RAB9ASMN1; SMN2KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230240953-A1 | AN ANTIMICROBIAL COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2023-08-03 | — | — | US | claimed |
| EP-4171531-A1 | AN ANTIMICROBIAL COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2023-05-03 | — | — | EP | claimed |
| US-20220030862-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2022-02-03 | — | — | US | claimed |
| US-11224222-B2 | Synergistic compositions of dehydroacetic acid and methods for reducing yellowing in various end-user compositions | ISP INVESTMENTS LLC (US) | 2022-01-18 | — | — | US | claimed |
| WO-2022005930-A1 | AN ANTIMICROBIAL COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2022-01-06 | — | — | WO | claimed |
| EP-3886582-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2021-10-06 | — | — | EP | claimed |
| WO-2020113211-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2020-06-04 | — | — | WO | claimed |
| EP-3280449-B1 | AN AQUEOUS MULTILAMELLAR COMPOSITION FOR DELIVERING HYDROPHOBIC SUBSTANCES | ISP INVESTMENTS LLC (US) | 2019-11-20 | — | — | EP | claimed |
| US-20180092357-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS | ISP INVESTMENTS LLC (US) | 2018-04-05 | — | — | US | claimed |
| US-20180092843-A1 | AN AQUEOUS MULTILAMELLAR COMPOSITION FOR DELIVERING HYDROPHOBIC SUBSTANCES | ISP INVESTMENTS LLC (US) | 2018-04-05 | — | — | US | claimed |
| WO-2016154511-A1 | SYNERGISTIC COMPOSITIONS OF DEHYDROACETIC ACID AND METHODS FOR REDUCING YELLOWING IN VARIOUS END-USER COMPOSITIONS | ISP INVESTMENTS INC. (US) | 2016-09-29 | — | — | WO | claimed |
| EP-2547208-B1 | BIOCIDE POWDER FORMULATION | TROY TECHNOLOGY II INC (US) | 2016-07-27 | — | — | EP | claimed |
| US-20130310428-A1 | THERMO-STABLE, ARSENIC-FREE SYNERGISTIC BIOCIDE CONCENTRATE COMPOSITION FOR POLYMER MATRICES AND PROCESS FOR PREPARING SAME | ISP INVESTMENTS INC. (US) | 2013-11-21 | — | — | US | claimed |
| US-20130195947-A1 | BIOCIDE POWDER FORMULATION | TROY TECHNOLOGY II, INC. | 2013-08-01 | — | — | US | claimed |
| EP-2547208-A1 | BIOCIDE POWDER FORMULATION | Isp Investments Inc. (US) | 2013-01-23 | — | — | EP | claimed |
| WO-2012024097-A1 | THERMO-STABLE, ARSENIC-FREE SYNERGISTIC BIOCIDE CONCENTRATE COMPOSITION FOR POLYMER MATRICES AND PROCESS FOR PREPARING SAME | ISP INVESTMENTS INC. (US) | 2012-02-23 | — | — | WO | claimed |
| WO-2011116168-A1 | BIOCIDE POWER FORMULATION | ISP INVESTMENTS INC. (US) | 2011-09-22 | — | — | WO | claimed |
| US-7951852-B2 | Mixing a microbiocide such as iodopropynyl butyl carbamate with a dry lubricant such as calcium stearate or zinc stearate to form a free-flowing powder additive for polymer, plastic, or polymer-wood composites | ISP INVESTMENTS INC. (US) | 2011-05-31 | — | — | US | claimed |
| US-20060229381-A1 | Free-flowing composition of a biocide and a processing additive therewith for incorporation into a polymer or plastic matrix product | ISP INVESTMENTS INC. | 2006-10-12 | — | — | US | claimed |
| US-20060013847-A1 | Thermal stabilization of IPBC biocide | ISP INVESTMENTS INC. | 2006-01-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180092843-A1 | AN AQUEOUS MULTILAMELLAR COMPOSITION FOR DELIVERING HYDROPHOBIC SUBSTANCES | LIPA, PHOSPHO1, DAGLA | RAB9A 3736/4885SMN1; SMN2 4222/4885KDM4E 2953/4885 |
| US-20230240953-A1 | AN ANTIMICROBIAL COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | MPO, SPOUT1, ARG1 | RAB9A 1895/4885SMN1; SMN2 3861/4885KDM4E 3897/4885 |
| US-20180092357-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS | PIEZO1, CASP1, PRNP | RAB9A 4177/4885SMN1; SMN2 1139/4885KDM4E 3639/4885 |
| US-20220030862-A1 | SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | HPD, EBP, TET1 | RAB9A 4741/4885SMN1; SMN2 3656/4885KDM4E 567/4885 |
| US-11224222-B2 | Synergistic compositions of dehydroacetic acid and methods for reducing yellowing in various end-user compositions | ALAD, SCD, DHCR7 | RAB9A 3330/4885SMN1; SMN2 3041/4885KDM4E 3071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.